- ►annals.org PJM Best, PB Berger, VM Miller, A Lerman - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Estrogen replacement therapy (ERT) in postmenopausal women ... Cited by 154 - Related articles - BL Direct - All 5 versions
O Ylikorkala, A Orpana, J Puolakka, T Pyorala, … - Journal of Clinical Endocrinology & Metabolism, 1995 - Endocrine Soc Page 1. Journal of Clinical Endocrinology and Metabolism Copyright 0 1995
by The Endocrine Society Vol. 80, No. 11 Printed in USA ... Cited by 109 - Related articles - BL Direct - All 7 versions
MD Ylikorkala… - Fertility and sterility, 1998 - Elsevier Objective: Oral postmenopausal hormone replacement therapy (HRT) decreases the
risk of cardiovascular disorders, but the mechanisms of this protection are
largely unknown. We compared the long-term effects of sequential oral HRT ... Cited by 59 - Related articles - BL Direct - All 11 versions
- ►endojournals.org B Imthurn, M Rosselli, AW Jaeger, PJ Keller, … - Journal of Clinical Endocrinology & Metabolism, 1997 - Endocrine Soc Although it is now well accepted that in women estrogen induces cardioprotective
effects, the mechanism(s) of estrogen-induced cardioprotective effects remains
unclear. Therefore, we hypothesize that estrogen-induced cardioprotection ... Cited by 83 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org V Guetta, AA Quyyumi, A Prasad, JA Panza, … - Circulation, 1997 - Am Heart Assoc Methods and Results To assess the contribution of nitric oxide (NO) to the
vascular effects of estradiol, we measured coronary epicardial and microvascular
responses to intracoronary acetylcholine (range, 3 to 300 µg/min for 2 ... Cited by 213 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org M Rosselli, B Imthurn, PJ Keller, EK Jackson … - Hypertension, 1995 - Am Heart Assoc Abstract Postmenopausal women (PMW) have an increased risk of cardiovascular
disease that is attenuated by hormone replacement therapy (HRT). Inasmuch as
hypertension and atherosclerosis are associated with diminished endothelium- ... Cited by 216 - Related articles - BL Direct - All 4 versions
JG Wilcox, IE Hatch, E Gentzschein, FZ … - Fertility and sterility, 1997 - Elsevier To establish levels of plasma endothelin-1 in postmenopausal women with
increased CV risk as compared with healthy premenopausal women and to measure
the effects of different forms of estrogen replacement on plasma endothelin-1. Cited by 58 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org KE Sorensen, I Dorup, AP Hermann, L … - Circulation, 1998 - Am Heart Assoc Methods and Results—We studied endothelial vasomotor function in 100 healthy
postmenopausal women aged 53.3±2.9 years randomized to either combined hormone
replacement therapy (n=46) or no substitution (n=54) 2.9±0.5 years ... Cited by 152 - Related articles - BL Direct - All 7 versions
ME Mendelsohn - Journal of Steroid Biochemistry and Molecular Biology, 2000 - Elsevier The incidence of cardiovascular disease differs significantly between men and
women due to a number of complex factors [1 and 2]. The incidence of
atherosclerotic diseases is low in premenopausal women, rises significantly ... Cited by 78 - Related articles - BL Direct - All 6 versions
